| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| flumazenil | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.24 | approved | antagonist |
| flumazenil | gamma-aminobutyric acid receptor subunit alpha-1 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.24 | approved | antagonist,allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.24 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.24 | approved | positive allosteric modulator,allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor alpha-2 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator,allosteric modulator |
| flumazenil | gaba(a) receptor alpha-2 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | unknown |
| flumazenil | gaba(a) receptor alpha-3 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator,allosteric modulator |
| flumazenil | gaba(a) receptor alpha-3 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | unknown |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | positive allosteric modulator |
| flumazenil | gamma-aminobutyric acid receptor subunit alpha-5 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | antagonist |
| flumazenil | gaba(a) receptor alpha-5 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | allosteric modulator |
| flumazenil | gaba(a) receptor alpha-5 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | unknown |
| flumazenil | gamma-aminobutyric acid receptor subunit alpha-5 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | antagonist,allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.25 | approved | positive allosteric modulator,allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | approved | positive allosteric modulator,allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | positive allosteric modulator |
| flumazenil | gamma-aminobutyric acid receptor subunit gamma-2 | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.2 | approved | antagonist |
| flumazenil | gaba(a) receptor gamma-3 | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | approved | unknown |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.09 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.05 | approved | positive allosteric modulator |
| flumazenil | gaba(a) receptor | small molecule | NA | drugbank , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.06 | approved | positive allosteric modulator |
| flumazenil | translocator protein | NA | Successful target | TTD , DGIDB | Disease Management[MeSHID:D019468] Diagnosis[MeSHID:D003933] Drug Overdose[MeSHID:D062787] Maintenance[MeSHID:D008283] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.1 | approved | unknown |
| click here to return to the previous page | ||||||||